<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01399268</url>
  </required_header>
  <id_info>
    <org_study_id>HSS-28116</org_study_id>
    <nct_id>NCT01399268</nct_id>
  </id_info>
  <brief_title>Steroids in Bilateral Total Knee Replacement</brief_title>
  <official_title>Effect of Steroids Given Over 24 Hours on Cytokine Release and Urinary Desmosine Levels in Patients Undergoing Bilateral Total Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inflammation related to cytokine release is known to occur with surgery. The cytokine IL6, a
      major marker of inflammation is known to increase during total joint replacement surgery. IL6
      has been found to be elevated postoperatively in patients with hip fractures and has been
      linked to mental status changes and possibly other complications. It is known to lead to
      shock and participate in the inflammatory state seen in sepsis. High levels have further been
      linked to postoperative fever, confusion, symptoms of depression, acute respiratory distress
      syndrome (ARDS) and fat embolism syndrome (FES). Previously the investigators found that low
      dose steroids given in two doses in the initial perioperative period decreased the amount of
      IL6 released compared to placebo, but this was not sustained past 24 hours.

      Desmosine is a stable breakdown product of elastin from lung tissue that can be measured in
      urine samples. It is considered to be a marker of lung injury and is found to be elevated in
      patients with ARDS, congestive obstructive pulmonary disease and FES. Previously, the
      investigators have found that urine desmosine levels rise with bilateral total knee
      replacement compared to unilateral total knee replacement indicating possible lung injury.

      Therefore the investigators hypothesize:

      Continued low dose steroids given three times over a 24 hour period will:

        1. Significantly decrease peak IL6 cytokine release during bilateral total knee replacement
           and maintaining this reduction in IL6 beyond 24 hours.

        2. Decrease urinary desmosine levels, and hence be protective of lung injury.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in IL6 Level</measure>
    <time_frame>24 hours postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Desmosine Level</measure>
    <time_frame>24 hours postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Glucose</measure>
    <time_frame>24 hours postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Length of hospital stay, an expected average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In Hospital Infection Rate</measure>
    <time_frame>Length of hospital stay, an expected average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Length of hospital stay, an expected average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to Ambulate</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Postoperative Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>Steroid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrocortisone 100 mg IV Q 8hrs x3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline IV Q8hr x3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
    <arm_group_label>Steroid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for bilateral total knee replacement

          -  Between 50-90 years of age

        Exclusion Criteria:

          -  Patients on steroid therapy

          -  Patients that require stress-dose steroid pre-operatively

          -  Patients that smoke

          -  Patients that are diabetic

          -  Patients younger than 50 or older than 90 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kethy Jules-Elysee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2011</study_first_submitted>
  <study_first_submitted_qc>July 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2011</study_first_posted>
  <results_first_submitted>March 23, 2017</results_first_submitted>
  <results_first_submitted_qc>July 27, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 31, 2017</results_first_posted>
  <last_update_submitted>July 27, 2017</last_update_submitted>
  <last_update_submitted_qc>July 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bilateral total knee replacement</keyword>
  <keyword>cytokine</keyword>
  <keyword>desmosine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Steroid</title>
          <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Steroid</title>
          <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="7"/>
                    <measurement group_id="B2" value="71" spread="9"/>
                    <measurement group_id="B3" value="67.5" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Decrease in IL6 Level</title>
        <time_frame>24 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>Decrease in IL6 Level</title>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>99% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="359.4" lower_limit="300" upper_limit="400"/>
                    <measurement group_id="O2" value="381.6" lower_limit="300" upper_limit="400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Desmosine Level</title>
        <time_frame>24 hours postoperative</time_frame>
        <population>Data were not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>Desmosine Level</title>
          <population>Data were not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Glucose</title>
        <time_frame>24 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Glucose</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="133" spread="30"/>
                    <measurement group_id="O2" value="102" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <time_frame>Length of hospital stay, an expected average of 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="0.9"/>
                    <measurement group_id="O2" value="5" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In Hospital Infection Rate</title>
        <time_frame>Length of hospital stay, an expected average of 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>In Hospital Infection Rate</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality</title>
        <time_frame>Length of hospital stay, an expected average of 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ability to Ambulate</title>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
          </group>
        </group_list>
        <measure>
          <title>Ability to Ambulate</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The study collected data for 30 days after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Steroid</title>
          <description>Hydrocortisone 100 mg IV Q 8hrs x3
Hydrocortisone: Prepared by pharmacy, 100 mg, IV, every 8 hours, 3 times</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Saline IV Q8hr x3
Saline: Prepared by pharmacy same volume as study drug, IV, every 8 hours 3 times</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jules</name_or_title>
      <organization>HSS</organization>
      <phone>212.606.1206</phone>
      <email>JulesK@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

